CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to INCY

Phase 3

Development Phase

2

Upcoming Catalysts

1

Historical Events

1

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
INCYPhase 3

Povorcitinib Phase 3 Est. Readout (STOP-HS LTE)

Povorcitinib
Dec 2026~
CT.gov
00%
Nov '26
INCYPhase 2

povorcitinib Phase 2 Est. Readout

Povorcitinib
Nov 2026~
CT.gov
00%
Development History
Oct '26
INCYPhase 3
✓Completed

Povorcitinib Phase 3 Est. Readout

Povorcitinib
Oct 2026~
CT.gov
Competitive Landscape
Drug Information

Target Indication

NonSegmental Vitiligo

Clinical Trial

NCT06113445

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMAPending

Povofortay

Treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.